Patents for C12N 7 - Viruses, e.g. bacteriophages; Compositions thereof; Preparation or purification thereof (26,637)
09/2012
09/11/2012CA2272820C An improved method for the production and purification of adenoviral vectors
09/11/2012CA2233867C Vector and method of use for nucleic acid delivery to non-dividing cells
09/07/2012WO2012118092A1 Fusion protein
09/07/2012WO2012117116A2 Enhanced tumor therapy by tumor stem cell targeted oncolytic viruses
09/07/2012WO2012117045A1 Infectious bronchitis virus (ibv) spike protein as subunit vaccine
09/07/2012WO2012116636A1 Oncolytic adenovirus for target therapy of human tumor and use thereof
09/07/2012WO2012061637A3 Hsv-1 epitopes and methods for using same
09/06/2012US20120225894 Substituted Thienol[2,3-d] pyrimidines as HIV Inhibitors
09/06/2012US20120225807 Bacterial membrane protein secretion
09/06/2012US20120225470 Methods of propagating monkey adenoviral vectors
09/06/2012US20120225045 Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions
09/05/2012EP2495322A1 Pro-clotting enzyme, and method for detection of (1 --> 3) -ß-D-glucan using the same
09/05/2012EP2495321A1 Pro-clotting enzyme, and method for detection of endotoxin using the same
09/05/2012EP2495314A1 Novel vaccine composition
09/05/2012EP2495256A1 Antibody having activity of inhibiting infection with hepatitis c virus (hcv) and use of same
09/05/2012EP2494987A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
09/05/2012EP2494986A1 Metapneumovirus strains and their use in vaccine formulations and as vectors for expression of antigenic sequences and methods for propagating virus
09/05/2012EP2494978A1 Enhanced tumor therapy by tumor stem cell targeted oncolytic viruses
09/05/2012EP2493912A1 High titer recombinant influenza viruses with enhanced replication in vero cells
09/05/2012CN1977050B Determination of hepatitis c virus genotype
09/05/2012CN1961001B Polypeptide sequence involved in the modulation of the immunosuppresive effect of viral proteins
09/05/2012CN102653772A Compositions of erythropoietin isoforms comprising lewis-x structures and high sialic acid content
09/05/2012CN102653731A Recombined infectious bovine rhinotracheitis virus with deletion of gG, TK and gE genes
09/05/2012CN102018957B Production method of hog cholera live vaccine
09/05/2012CN101947318B Method for preparing porcine parvovirus inactivated vaccines
09/05/2012CN101906404B Avian infectious bronchitis virus (IBV) as well as culture method and application thereof
09/05/2012CN101905020B Method for producing swine fever vaccines
09/05/2012CN101851608B Method for producing rabies viruses by suspension culture of BHK21 cells
09/05/2012CN101816786B Inactivated hepatitis A vaccine and preparation method thereof
09/05/2012CN101745108B Avian influenza vaccine and preparation method thereof
09/05/2012CN101724636B Asial type foot-and-mouth disease virus (FMDV) infectious cDNA and construction method as well as application thereof
09/05/2012CN101717754B Enterovirus type 71 and use thereof
09/05/2012CN101709292B Recombinant adenovirus, and preparation method and application thereof
09/05/2012CN101497877B Influenza all-virus attenuated live vaccine recombinant, construction method and use thereof
09/05/2012CN101460627B Process for producing poxviruses and poxvirus compositions
09/05/2012CN101426535B DNA virus microrna and methods for inhibiting same
09/05/2012CN101115830B Method of retrovirus storage
09/05/2012CN101014613B Chimpanzee adenovirus vaccine carriers
09/04/2012CA2520279C Mutant vesicular stomatitis viruses and use thereof
09/04/2012CA2414339C Bvdv virus-like particles
09/04/2012CA2243261C Methods for delivering dna to muscle cells using recombinant adeno-associated virus virions
08/2012
08/30/2012WO2012115474A2 Novel varicella-zoster virus strains, and chicken pox and herpes zoster virus vaccine using same
08/30/2012WO2012115227A1 Mycovirus, phytopathogenic fungus, plant disease controlling agent, method for controlling plant disease, and method for attenuating phytopathogenic fungus
08/30/2012WO2012114520A1 Attenuated virus of lily mottle virus
08/30/2012US20120219588 Methods for purification of viruses
08/30/2012US20120219528 Excipients for use in adeno-associated virus pharmaceutical formulations, and pharmaceutical formulations made therewith
08/30/2012DE102010054766B4 Verfahren zur Trennung, Aufkonzentration oder Reinigung eines (Blut)Plasmaproteins oder Virenbestandteils aus einer Mischung Process for the separation, concentration or purification of a (blood) plasma protein or virus component of a mixture
08/29/2012EP2491961A1 Composition for inducing tissue regeneration by activating platelet-rich plasma (prp), and method for manufacturing same
08/29/2012EP2491118A2 Construct for production of empty picornaviral capsids
08/29/2012EP2491117A1 Improved reverse genetics methods for virus rescue
08/29/2012EP2490716A1 Detection of a circovirus in calves suffering from bovine neonatal pancytopenia
08/29/2012EP2008664B1 Modified proteins which bind extracellular matrix components
08/29/2012CN102649963A Human papillomavirus (HPV) L1-based recombinant adenovirus for preventing and treating esophagus cancer
08/29/2012CN102649948A Infectious bovine rhinotracheitis delta TK/delta gE gene deletion mark live vaccine and preparation method
08/29/2012CN102649812A Powdery mildew resistance-related protein TaWRKY1 and coding gene thereof
08/29/2012CN102649811A Protein TaWRKY2 related to powdery mildew resistance and coding gene of protein TaWRKY2
08/29/2012CN101979598B Method for constructing HSV-1 BAC system carrying luciferase report genes
08/29/2012CN101979549B Gene medicament taking voltage-gated proton channel Hv1 as targeted locus for treatment of breast cancer
08/29/2012CN101928345B Human source antibody and humanization remolding method thereof
08/28/2012US8252923 Peptidomimetic protease inhibitors
08/28/2012US8252576 Use of prokaryote viruses to remediate bio-fouling
08/28/2012US8252574 Pseudoinfectious flavivirus and uses thereof
08/28/2012US8252537 5' portion of an intestinal lactase-phlorizine hydrolase (LPH) gene; point mutations; solid phase synthesis; immunoassay; vectors; primers; host cells; antibodies; kits; gene therapy
08/28/2012US8252519 Process for continuous production of bacteriophage
08/28/2012CA2450470C Method for rapid screening of bacterial transformants and novel simian adenovirus proteins
08/28/2012CA2412531C Antimicrobial peptides and methods of use thereof
08/28/2012CA2399172C Cold-adapted equine influenza viruses
08/23/2012WO2012110490A1 Commercial scale process for production of prrsv
08/23/2012WO2012110489A2 Novel european prrsv strain
08/23/2012WO2012087037A3 Novel bacteriophage and antibacterial composition comprising the same
08/23/2012US20120214240 Vectors for generating pluripotent stem cells and methods of producing pluripotent stem cells using the same
08/23/2012US20120213814 Modification of recombinant adenovirus with immunogenic plasmodium circumsporozoite protein epitopes
08/23/2012US20120213810 Novel european prrsv strain
08/23/2012US20120213741 Commercial scale process for production of prrsv
08/23/2012CA2827337A1 Commercial scale process for production of prrsv
08/23/2012CA2826341A1 Novel european prrsv strain
08/22/2012EP2489275A1 CRISPR escape phage mutants
08/22/2012EP2488636A1 Method for the purification of adenovirus particles
08/22/2012EP2488635A1 Process for adenovirus purification from high cell density cultures
08/22/2012EP2488634A1 Isolation of a virus related to canine parvovirus-2 from a raccoon
08/22/2012EP2488633A1 In vitro method for obtaining intrahepatic fibroblasts infected with hepetitis c virus
08/22/2012EP2460878A9 Orf7 deficient varicella virus, vaccine comprising the virus and use thereof
08/22/2012EP1383796B2 Neurovirulent strain of the west nile virus and applications thereof
08/22/2012CN1934248B HBV variants detection and application
08/22/2012CN102648000A Novel influenza virus
08/22/2012CN102643819A ShRNA of Rab23 and ientiviral vector and applications thereof
08/22/2012CN102643777A Oligopeptide-free cell culture media
08/22/2012CN102051358B Mosaic tumor specific gene expression regulation kit and application thereof
08/22/2012CN102038942B Method for industrially producing porcine reproductive and respiratory syndrome (PRRS) vaccines by utilizing bioreactor
08/22/2012CN101955917B Virus-like particle containing porcine parvovirus VP2 and somatostatin chimeric protein
08/22/2012CN101942419B Dog parvovirus attenuated vaccine strain and application thereof
08/21/2012US8247207 Refrigerator-temperature stable influenza vaccine compositions
08/21/2012US8247167 HIV-1 latency model for high throughput screening
08/21/2012CA2450206C Improved yield of chordopoxvirus by propagation at low temperature
08/21/2012CA2424400C Adaptation sites of prrsv
08/18/2012CA2768801A1 Generation of virus-like particles and use as panfilovirus vaccine
08/16/2012WO2012107614A1 Vaccine against african swine fever virus, based on replication deficient recombinant viruses
08/16/2012US20120210460 Nitrate-responsive promoter
08/16/2012US20120208870 Hepatitis c virus codon optimized non-structural ns3/4a fusion gene
08/16/2012US20120208280 Brucella phage polynucleotides and uses thereof
1 ... 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 ... 267